CHM 0.00% 2.1¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-6

  1. 764 Posts.
    lightbulb Created with Sketch. 525
    It's silly cheap.

    As Dr Maiti said, "We should find out pretty early on." It's all about pushing those deep remissions back. His goal is to increase overall survival rate by 10-15%, " but if the trials follow the clinical data it could be much much higher. "


 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $18.39M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $9.959K 474.2K

Buyers (Bids)

No. Vol. Price($)
6 1322541 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 32523 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.